Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: Implications for technetium-99-m- sestamibi imaging

Journal of Nuclear Medicine

Volumn 39, Issue 3, 1998, Pages 417-425

  Wu, Joseph C ^a   Yun, James J ^a   Heller, Eliot N ^a   Dione, Donald P ^a   DeMan, Paul ^a   Liu, Yi Hwa ^a   Zaret, Barry L ^a   Wackers, Frans J Th ^a   Sinusas, Albert J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood flow; Coronary artery disease; Dobutamine; Stress perfusion imaging; Technetium 99m sestamibi scintigraphy

Indexed keywords

DOBUTAMINE; MICROSPHERE;

ANIMAL MODEL; ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DOG; HEART MUSCLE BLOOD FLOW; IMAGE ANALYSIS; ISOTOPE LABELING; MYOCARDIAL DISEASE; NONHUMAN; PHYSICAL STRESS; PRIORITY JOURNAL; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CARDIOTONIC AGENTS; CORONARY CIRCULATION; CORONARY DISEASE; DOBUTAMINE; DOGS; HEART; MICROSPHERES; MYOCARDIAL CONTRACTION; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031905215     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Richie JL, Trobaugh GB, Hamilton GW, Gould KL, Narahara KA. Myocardial imaging with thallium-201 at rest and during exercise: comparison with coronary arteriography and resf and stress electrocardiography. Circulation 1977;56:66-76.
2. Pearlman JD, Boucher CA. Diagnostic value for coronary artery disease of chest pain during dipyridamole-thallium stress testing. Am J Cardiol 1988;61:43-45.
3. Verani MS, Mahmarian JJ, Hixson JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990;82:80-87.
4. Mannering D, Cripps T, Leech G, Valentine H, Gilmour S, Bennett E. The dobutamine stress test as an alternative to exercise testing after acute myocardial infarction. Br Heart J 1988;59:521-526.
5. Kiat H, Iskandrian A, Villegas B, Starling M, Berman D. Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system. J Am Coll Cardiol 1995;26:1159-1167.
6. Beller GA. Pharmacologic stress imaging. J Am Med Assoc 1991;265:633-638.
7. Leppo JA. Dipyridamole-thallium imaging: the lazy man's stress test. J Nucl Med 1989;30:281-287.
8. Iskandrian AS. Single-photon emission computed tomographic thallium imaging with adenosine, dipyridamole, and exercise. Am Heart J 1991;122:279-284.
9. Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993;21:1583-1590.
10. Mason J, Palac R, Freeman M, et al. Thalllium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease. Am Hean J 1984;107:481-485.
11. Pennell D, Underwood R, Swanton H, Walker M, Ell P. Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 1991;18:1471-1479.
12. Herman S, LaBresh K, Santos-Oscampo C, et al. Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease. Am J Cardiol 1994;73:164-169.
13. 99mTc-MIBl single-photon emission tomography: non-exercise-dependent detection of haemodynamically significant coronary artery stenoses. Ear J Nucl Med 1994;21:537-544.
14. Marwick T, Willemart B, D'Hondt A, et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Circulation 1993;87:345-354.
15. Shi C, Sinusas AJ, Dione DP, et al. Technetium-99m-nitroimidazole (BMS181321): a positive imaging agent for detecting myocardial ischemia. J Nucl Med 1995;36:1078-1086.
16. Heymann MA, Payne BD, Huffman JE, Rudolph AM. Blood flow measurements with radionuclide labeled particles. Prog Cardiovasc Dis 1977;20:55-79.
17. Hartley CJ, Latson LA, Michael LH, Seidel CL, Lewis RM, Entman ML. Doppler measurement of myocardial thickening with a single epicardial transducer. Am J Physiol 1983;245:H1066-H1072.
18. Liu YH, Sinusas AJ, Shi CQX, et al. An automated approach for quantification of relative regional myocardial blood flow, using SPECT Tc99m-sestamibi: preliminary validation in a canine model. Proc 16th Annu Int Conf IEEE Eng Med Biol Soc Baltimore, MD 1994; 636-638.
19. Wackers FJ. Exercise myocardial perfusion imaging. J Nucl Med 1994;35:726-729.
20. Sigal SL, Soufer R, Fetterman RC, Mattera JA, Wackers FT. Reproducibility of quantitative planar thallium-201 scintigraphy: quantitative criteria for reversibility of myocardial perfusion defects. J Nucl Med 1991;32:759-765.
21. Sinusas A, Watson D, Cannon J, Beller G. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyle isonitrile and thallium-201. J Am Coll Cardiol 1989;14:1785-1793.
22. Okada RD, Glover D, Gaffhey T, Williams S. Myocardial kinetics of technetium-99mhexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988;77:491-498.
23. Glover DK, Okada RD. Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole. Circulation 1990;81:628-636.
24. Gosselin RE, Stibitz GR. Rates of solute absorption from tissue depots: theoretical consideration. Pfluegers Arch Ear J Physiol 1970;318:85-98.
25. Cerqueira MD. Assessment of myocardial perfusion and viability. In: Cerqueira MD, ed. Nuclear cardiology. Boston: Blackwell Scientific Publications: 1994:118-176.
26. Ruiz M, Dennis AC, Desta H, et al. Tc99m-sestamibi (MIBI) defect magnitude during dobutamine stress underestimates the magnitude of ischemia in dogs with mild coronary stenoses [Abstract]. J Am Coll Cardiol 1996;27(suppl A):353A.
27. Glover DK, Ruiz M, Edwards NC, et al. Comparison between T1-201 and Tc99m-sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation 1995;91:813-820.
28. Melon PG, Beanlands RS, DeGrado TR, Nguyen N, Petty NA, Schwaiger M. Comparison of technetmm-99m sestamibi and thallium-201 retention characteristics in canine myocardium. J Am Coll Cardiol 1990;20:1277-1283.
29. Kiat H, Maddahi J, Roy LT, et al. Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989;117:1-11.
30. Kahn JK, McGhie I, Akers MS, et al. Quantitative rotational tomography with 201T1 and 99mTc 2-methoxy-isobutyle-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989;79:1282-1293.
31. Larock MP, Cantineau R, Legrand V, Kulbertus H, Rigo P. 99mTc-MIBI (RP-30) to define the extent of myocardial ischemia and evaluate ventricular function. Eur J Nucl Med 1990;16:223-230.
32. Zinemanas D, Beyar R, Sideman S. Effects of myocardial contraction on coronary blood flow: an integrated model. Ann Biomed Eng 1994;22:638-652.
33. Tuttle RR, Mills J. Development of a new catecholamine to selectively increase cardiac contractility. Circ Res 1975;36:185-196.
34. Zellner JL, Elliot BM, Robinson JG, Hendrix GH, Spicer KM. Preoperative evaluation of cardiac risk using dobutamine-thallium imaging in vascular surgery. Ann Vasc Surg 1990;4:238-243.
35. Krivokapich J, Czernin J, Scheiben HR. Dobulamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease. J Am Coll Cardiol 1996;28:565-572.
36. Stoddard MF, Prince CR, Morris GT. Coronary flow reserve assessment by dobutamine transesophageal Doppler echocardiography. J Am Coll Cardiol 1995;25:325-332.
37. De Bruyne B, Bartunek J, Sys SU, Pijls NH, Heyndrickx GR, Wijns W. Simultaneous coronary pressure and flow velocity measurements in humans: feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation 1996;94:1842-1849.
38. Sun KT, Czernin J, Krivokapich J, et al. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 1996;94:3146-3154.
39. Zhang J, Path G, Chepuri V, et al. Effects of dobutamine on myocardial blood flow, contractile function, and bioenergetic responses distal to coronary stenosis: implications with regard to dobutamine stress testing. Am Heart J 1995;129:330-342.
40. Pierard L, De Landsheere C, Berthe C, Rigo P, Kulbertus H. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardial 1990;15:1021-1031.
41. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-626.
42. Severi S, Underwood R, Mohiaddin R, Boyd H, Paterni M, Camici P. Dobutamine stress: effects on regional myocardial blood flow and wall motion. J Am Coll Cardiol 1995;126:1187-1195.
43. Forster T, McNeill AJ, Salustri A, et al. Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol 1993;21:1591-1596.
44. Senior R, Sridhara B, Anagnostou E, Handler C, Raftery E, Lahiri A. Synergistic value of simultaneous stress dobutamine sestamibi single-photon-emission computerized tomography and echocardiography in the detection of coronary artery disease. Am Heart J 1994;128:713-718.
45. Hoffman R, Lethen H, Kleinhans E, Weiss M, Flachskampf FA, Hanrath P. Comparative evaluation of bicycle and dobutamine stress echocardiography with perfusion scintigraphy and bicycle electrocardiogram for identification of coronary artery disease. Am J Cardiol 1993;72:555-559.
46. Marwick TH, D'Hondt AM, Mairesse GH, et al. Comparative ability of dobutamine and stress in inducing myocardial ischaemia in active patients. Br Heart J 1994;72: 31-38.
47. Mairesse GH, Marwick TH, Vanoverschelde JL, et al. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxy isobutyl isonitrile (mibi) perfusion scintigraphy. J Am Coll Cardiol 1994;24:920-927.
48. 99mTc-sestamibi defect size. Circulation 1993;88:2224-2234.
49. Kloner R, Allen J, Cox T, Zheng Y, Ruiz C. Stunned left ventricular myocardium after exercise treadmill testing in coronary artery disease. Am J Cardiol 1991;68:329-334.
50. Nematzadeh D, Kim YD, Rose JC, Wolf PH, MacNamara TE, Kot PA. Effects of halothane on the intramyocardial pressure of the canine left ventricle. Cardiovasc Res 1985;20:275-281.
51. Buljubasic N, Stowe DF, Marijic J, Roerig DL, Kampine JP, Bosajak Z. Halothane reduces release of adenosine, inosine, and lactate with ischemia and reperfusion in isolated hearts. Anesthesia Analgesia 1993;73:54-62.
52. Fung A, Gallagher K, Buda A. The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation 1987;76:943-951.
53. Calnon DA, Glover DK, Vanzetto G, et al. Dobutamine stress Tc-99m sestamibi uptake underestimates the magnitude of ischemia in dogs with mild and critical coronary stenoses [Abstract]. J Nucl Med 1996;37:3P.